Involvement of the L-DOPA receptor GPR143 in acute and chronic actions of methylphenidate
Methylphenidate (MPH) and methamphetamine (METH) are the current treatments of choice for attention deficit/hyperactivity disorder. We previously reported that METH induces the release of dopamine (DA) and of the neurotransmitter candidate L-3,4-dihydroxyphenylalanine (L-DOPA). In contrast, we here...
Saved in:
Main Authors: | Hiraku Uchimura (Author), Kaori Kanai (Author), Masami Arai (Author), Miyu Inoue (Author), Akitoyo Hishimoto (Author), Daiki Masukawa (Author), Yoshio Goshima (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease
by: Yoshio Goshima, et al.
Published: (2019) -
Genetic associations of single nucleotide polymorphisms in the l-DOPA receptor (GPR143) gene with severity of nicotine dependence in Japanese individuals, and attenuation of nicotine reinforcement in Gpr143 gene-deficient mice
by: Daiki Masukawa, et al.
Published: (2020) -
l-3,4-Dihydroxyphenylalanine induces ptosis through a GPR143-independent mechanism in mice
by: Suguru Ueda, et al.
Published: (2016) -
Overexpression of the gene product of ocular albinism 1 (GPR143/OA1) but not its mutant forms inhibits neurite outgrowth in PC12 cells
by: Daiki Masukawa, et al.
Published: (2019) -
Right ventricular overloading is attenuated in monocrotaline-induced pulmonary hypertension model rats with a disrupted Gpr143 gene, the gene that encodes the 3,4-l-dihydroxyphenyalanine (l-DOPA) receptor
by: Masayuki Nakano, et al.
Published: (2022)